In contrast, IL-6 deficient mice show mature-onset obesity and hepatic inflammation, and IL-6 administration reverses insulin resistance (Wallenius et al., 2002; Matthews et al., 2010). This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.